JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1996) 16, 297-306    DOI: 10.1677/jme.0.0160297
© 1996 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aprikian, A G
Right arrow Articles by Viallet, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aprikian, A G
Right arrow Articles by Viallet, J

Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells

A G Aprikian, K Han, S Chevalier, M Bazinet and J Viallet

Bombesin and gastrin-releasing peptide (GRP) are potent neuropeptides expressed by prostate cancer neuroendocrine cells and are related to the progression of this malignancy. This study characterizes bombesin receptors in human prostate cancer cell lines (PC-3, DU-145, LNCaP) and assesses the in vitro effect of bombesin on signal transduction and cell proliferation. [125I]Tyr4-bombesin binding assays (37 °C) and Scatchard analyses revealed the presence of a single class of high-affinity receptors with similar Kd values (1·5, 1·1 and 3·6 x 10–10 M in PC-3, DU-145 and LNCaP cells respectively) but with significant differences in the number of binding sites per cell (47·6, 1·5 and 0·1 x 103 in PC-3, DU-145 and LNCaP cells respectively). Molecular characterization of the binding sites performed in PC-3 cells by cross-linking experiments and SDS/PAGE revealed a single radioactive band of 85 kDa. To determine which of the three known bombesin receptor subtypes (GRP receptor (GRP-R), neuromedin B receptor, bombesin receptor subtype-3) were expressed in the cell lines, reverse transcription/PCR analysis of cellular RNA followed by hybridization with receptor-specific cDNA was performed. This revealed the presence of GRP-R transcript in all cell lines, while neither of the other two receptor transcripts were expressed. When intracellular calcium mobilization was measured by Fura-2/AM cell labeling and spectrofluorometric monitoring, bombesin (100 nM) induced rapid calcium mobilization in both PC-3 (>200% of baseline) and DU-145 (>100% of baseline) cells, but not in LNCaP cells. However, as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and [3H]thymidine incorporation, no growth modulation was observed with bombesin or bombesin receptor antagonist at various concentrations (0-500 nM). Our data indicate that bombesin is a potent inducer of signal transduction via GRP-R receptors in androgen-insensitive PC-3 and DU-145 prostate cancer cells. This suggests that the bombesin/GRP family of neuropeptides may play a regulatory role in the biology of androgen-independent prostate cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. C. Yang, J.-h. Ok, J. E. Busby, A. D. Borowsky, H.-J. Kung, and C. P. Evans
Aberrant Activation of Androgen Receptor in a New Neuropeptide-Autocrine Model of Androgen-Insensitive Prostate Cancer
Cancer Res., January 1, 2009; 69(1): 151 - 160.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Salah, M. Maoz, G. Pizov, and R. Bar-Shavit
Transcriptional Regulation of Human Protease-Activated Receptor 1: A Role for the Early Growth Response-1 Protein in Prostate Cancer
Cancer Res., October 15, 2007; 67(20): 9835 - 9843.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. J. Desai, A.-H. Ma, C. G. Tepper, H.-W. Chen, and H.-J. Kung
Inappropriate Activation of the Androgen Receptor by Nonsteroids: Involvement of the Src Kinase Pathway and Its Therapeutic Implications
Cancer Res., November 1, 2006; 66(21): 10449 - 10459.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Xiao, D. Chinnappan, R. Pestell, C. Albanese, and H. C. Weber
Bombesin Regulates Cyclin D1 Expression through the Early Growth Response Protein Egr-1 in Prostate Cancer Cells
Cancer Res., November 1, 2005; 65(21): 9934 - 9942.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L.-F. Lee, J. Guan, Y. Qiu, and H.-J. Kung
Neuropeptide-Induced Androgen Independence in Prostate Cancer Cells: Roles of Nonreceptor Tyrosine Kinases Etk/Bmx, Src, and Focal Adhesion Kinase
Mol. Cell. Biol., December 15, 2001; 21(24): 8385 - 8397.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Hellmich, K. L. Ives, V. Udupi, M. S. Soloff, G. H. Greeley Jr., B. N. Christensen, and C. M. Townsend Jr.
Multiple Protein Kinase Pathways Are Involved in Gastrin-releasing Peptide Receptor-regulated Secretion
J. Biol. Chem., August 20, 1999; 274(34): 23901 - 23909.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Markwalder and J. C. Reubi
Gastrin-releasing Peptide Receptors in the Human Prostate: Relation to Neoplastic Transformation
Cancer Res., March 1, 1999; 59(5): 1152 - 1159.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society for Endocrinology.